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ScienceDirectHuman Embryonic Stem Cells (hESCs) are in vitro derivatives of
the inner cell mass of the blastocyst and are characterized by
an undifferentiated and pluripotent state that can be
perpetuated in time, indefinitely. hESCs provide a unique
opportunity to both dissect the molecular mechanisms that are
predisposed to the maintenance of pluripotency and model the
ability to initiate differentiation and cell commitment within the
developing embryo. To fully understand these mechanisms, it
is necessary to accurately identify the specific transcriptome of
hESCs. Many distinct gene annotation methods, such as cDNA
and EST sequencing and RNA-Seq, have been used to identify
the transcriptome of hESCs. Lately, we developed a new tool
(IDP) to integrate the hybrid sequencing data to characterize a
more reliable and comprehensive hESC transcriptome with
discoveries of many novel transcripts.
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Introduction
Pluripotency is defined as the ability of a cell or group of
cells to differentiate to all the cells of an adult body,
including germ cells. In nature, pluripotency is a transient
feature that characterizes a group of cells in the preim-
plantation embryo (the inner cell mass in the blastocyst)
and in the early peri- and post-implantation embryo (the
epiblast). Human Embryonic Stem Cells (hESCs) can be
derived in vitro from human blastocysts and are charac-
terized by an undifferentiated and pluripotent state that
can be perpetuated in time, indefinitely. hESCs provide a
unique opportunity to both dissect the molecular mech-
anisms that are required to maintain pluripotency and
model the ability to initiate differentiation and cellwww.sciencedirect.com commitment within the developing embryo. In order to
understand mechanisms that function in maintaining
pluripotency and directing differentiation, it is beneficial
to accurately identify the specific transcriptome of
hESCs.
Over the last decade, several methods based on Second
Generation Sequencing (SGS) have been used to try to
characterize the transcriptome. From late 1990s, conven-
tional gene annotation tools have included cDNA and
EST sequencing and Gene Identification Signature (GIS)
but these methods have proved to be low throughput and
expensive. The introduction of the RNA-Seq technology
based on SGS has provided a remarkable step forward
providing a fast and inexpensive way to determine the
transcriptome of a given cell type and several remarkable
works have been done using this type of approach
[1,2,3]. Nonetheless tasks like de novo discovery of
genes, gene isoforms assembly or transcript and isoform
abundance determination are still challenging and far
from being achieved. Recently, we developed a new tool
(IDP) to integrate SGS and Third Generation Sequenc-
ing (TGS) data from human Embryonic Stem Cells (H1
cell line) and identified 13,543 transcripts with false
positive rate lower 5%, including 2103 novel transcripts
and 216 novel genes, 146 of which were deemed hESCs-
specific [4].
In this review we discuss the importance and the current
challenges in identifying the accurate transcriptome of
hESCs and human Induced Pluripotent Stem Cells
(hiPSCs) and show evidence of the reliability of IDP
in detecting and predicting annotated and novel genes
and their isoforms.
The transcriptional state of hESCs: what is
functionally relevant?
Many studies have revealed that human Pluripotent Stem
Cells (hPSCs, term that includes hESCs and hiPSCs) are
characterized by transcriptionally permissible chromatin
(i.e. accessible to a variety of transcription and remodeling
factors), a state compatible with increased global expres-
sion of genes and gene isoforms [5]. The transcriptionally
permissive chromatin is characterized by distinct epige-
netic marks (e.g. histone modifications) that define two
diverse types of genes: genes that are active in the
undifferentiated state and genes that are inactive (or
expressed at very low levels) but ‘‘poised’’ for expression
and that characterize more differentiated cell types [6].
Given such complexity of the epigenetic status for most
of the genes, it is essential to identify the transcripts and
the isoforms that are indeed functionally relevant (even ifCurrent Opinion in Genetics & Development 2014, 28:71–77
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hand that have a very low level of activation because
transcribed from loci that are only ‘‘poised’’ for transcrip-
tion but not really relevant at this stage of development. A
definitive answer to this problem would be provided by
the validation of expression of transcripts observed by
RNA-Seq (e.g. with other assays like RT-PCR) and most
importantly by functional studies. Although RNA-Seq
data have been produced from pluripotent cell samples,
such as embryonic stem cells and preimplantation
embryos at different developmental stages (from zygote
to late blastocyst) [3,7,8], experimental validation of
novel transcript expression and functional analysis of
many mRNAs is still lacking.
Novel genes
The vast majority of most recent research has focused on
determining the regulatory network of the well charac-
terized pluripotency genes, such as OCT4, SOX2 and
NANOG, or have concentrated on seeking for new mar-
kers from already annotated genes, such as ZFP296 [9]. In
addition, a few novel genes have been demonstrated to be
expressed and involved in the transcriptional network of
PSCs in mouse [10].
A few studies on mouse embryonic stem cells have ident-
ified a number of novel transcripts via various technologies
[11,12]. The accuracy of novel gene identification
depends on data quality and methods of annotation and
analysis: firstly, sequencing coverage on non-annotated
genome loci can indicate the existence of novel genes;
secondly, GIS can detect the 5’ and 3’end of transcripts and
thus provide accurate gene boundaries for novel gene
identification [10]; thirdly, EST and cDNA sequencing
is needed to validate and interpret the intron–exon struc-
tures of selected novel gene candidates [13,14], which is
low throughput and expensive. The other disadvantage of
EST and cDNA sequencing is the read length of
<1000 bp, which is far shorter than the median length of
human transcripts (2500 bp). Therefore, it is only likely
to capture fragments of novel transcripts. SGS provides a
fast and cost-effective way to predict novel genes and novel
gene isoforms. Unlike direct detection by EST and cDNA,
prediction methods are needed to assemble transcripts
from SGS data. However, more research and discussion
are needed for the validation rate. Au et al. made use of long
reads of TGS to directly capture the full-length or almost
full-length transcripts and thus provided more reliable
identifications of novel genes from hESCs. It should be
noted that discovery of novel genes/gene isoforms in
hESCs does not necessarily infer that they are uniquely
expressed by hESCs. As an example, two of the novel
genes (chr19:58826402-58838188 and chr1:143718512-
143744587) with high expression levels (RPKM, reads
per kilobase per million mapped reads) in hESCs
(35.1524 and 4.8801, respectively) but comparable expres-
sion was also observed in 16 adult tissues (Figure 1). BothCurrent Opinion in Genetics & Development 2014, 28:71–77 genes have isoforms containing three or more junctions but
were not reported before. The lack of annotation of these
genes could be due to the limits of gene annotation
methods or to the high degree of repetitive elements
within the sequences [15].
The differential analysis of 216 novel genes between
16 adult tissues and hESC revealed that a significant
subset (146 genes) had unique or relatively higher expres-
sion in hESCs. In this genes subset, the top 23 highest
expressed novel genes (named ‘‘HPAT’’ for Human
Pluripotency Associated Transcript) were all validated
to have specific expression in PSCs by comparing gene
abundance in H1, two iPSCs lines and fibroblasts by RT-
PCR. As an example, no annotated genes were reported in
RefSeq, Ensembl, Gencode or UCSC KnownGenes at
the locus of HPAT5 (chr6:167,641,868-167,659,274) [16–
19]. The long reads indicated complex intron-exon struc-
ture at this locus with at least 3 different transcribed
isoforms (Figure 1). The RPKM of this novel gene
HPAT5 was 31.94 in hESCs, a value much higher than
the average RPKM (0.53) detected in the other 16 adult
tissues.
However, it is notable that the specific expression does not
necessarily lead to the conclusion of pluripotency relevant
functions, such as the previously reported novel TU (Tran-
scription Unit) in mouse PSCs [10]. They could be
possibly the downstream regulation products of pluripo-
tency genes. Always, more solid evidences from functional
analysis are needed to extend specific gene expressions on
PSCs to their roles of pluripotency. For example, Kunarso
et al. characterized several novel protein-coding genes and
intergenic splicing isoforms from novel transcripts that
have specific expressions in mouse ESCs [10]. A similar
approach is needed for human ESCs. Au and colleagues
observed that several HPATs, which were not expressed in
parental fibroblasts were activated during reprogramming
and hiPSCs derivation with a kinetic very similar to that
observed for the pluripotency-associated genes like
NANOG, OCT4 and DNMT3B [4].
Non-coding RNAs and transposable elements
Several studies have recently demonstrated that the human
genome is transcriptionally active to an extent that was for
long underestimated. Transcription occurs across 80–90%
of the human genome, in contrast with the assumption that
only 3% (or less) of the genome is actually coding for
proteins. The vast majority of transcripts are represented
by tens of thousands of non-coding RNAs, functional
RNAs that play important regulatory roles in diverse bio-
logical processes. Interestingly, it has been recently shown
by several studies that a subgroup of these RNAs, called
Long intergenic non-coding RNAs (lincRNAs) has a sig-
nificant enrichment for transposable retroviral elements
(RE), which have contributed to their evolution and func-
tion acquisition [18,20,21,22,23,24,25,26,27].www.sciencedirect.com
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Figure 1
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Novel gene at chr6:167,641,267–167,660,912. The dark green track is the nonredundant long reads, each of which represents an alignment. The
strand of long read refers to the alignment of the read relative to the reference (i.e. aligned to reference or to reverse complement of reference)
and is not the direction of transcription. The naming of nonredundant long reads is A_Bjccs  D, where A is the percentage identity of BLAT
alignment, B is the length of alignment and D is the distance between the mappable part of long read and the polyA/polyT detection (‘‘+’’ is
forward strand and downstream while ‘‘-’’ is reverse strand and upstream). PacBio circular consensus sequence (CCS) reads are labeled with
‘‘ccs’’. The orange track is IDP predictions. The 35 bp mappability of this locus is in black. The light green track is Gencode annotation and the
brown one is Ensembl. RefSeq (light purple track) and UCSC Genes are also displayed but they have no annotated genes in this locus and thus
no IDP detections (referenced to RefSeq, red track) are displayed either [4].LincRNAs share many features with coding RNAs (e.g.
they are spliced and polyadenilated) but their very tight
and finely tuned tissue-specific and time-specific regula-
tion is probably driven by the co-option of transposable
retroviral elements [23]. These findings are extremely
interesting and will contribute to get a deeper insight into
the mechanisms of evolution, speciation and stem cell
homeostasis.
A specific class of RE-containing lincRNAs is specifically
expressed by PSCs [28,29]. These elements have a very
high degree of repetitive elements and it is therefore
extremely challenging to determine the correct gene
annotation and the abundance due to the difficulties in
aligning short read data to the genome. Furthermore the
discovery of novel loci that encode RE-containing lincR-
NAs has also proven to be difficult. In general, transpo-
sable elements are repetitive along the whole genome
and most of them are long. SGS short reads generated
from these regions are mappable to multiple genomic loci.
This alignment uncertainty prevents SGS from identify-
ing these lincRNAs. Au et al. characterized a few of such
lincRNAs by making use of the long read data from TGS.www.sciencedirect.com Importantly TGS long reads are long enough (1000–
20,000 bp) to at least capture some unique fragments
of the target lincRNAs and thus enabling the identifi-
cation of such lincRNAs and of their sequence structure
and complexity.
Novel gene isoforms
Gene isoforms are generated by alternative splicing, in
which exons are spliced and joined together in different
combinations. Alternative splicing is an important mech-
anism of gene function regulation since differences in the
mRNA sequences translate into distinct protein domains
with distinct roles. Alternative splicing can also affect the
5’ and 3’ UTRs that are essential for gene regulation.
Therefore, identifying the transcriptional variants of a
gene and the relative abundance of each of them is
instrumental to dissecting the functional role of such
gene. A large body of evidence has identified alternative
splicing differences between ESC and differentiated cell
populations [30,31,32].
Pluripotency regulation by the recently identified novel
isoform of FOXP1 in hESCs is a significant landmarkCurrent Opinion in Genetics & Development 2014, 28:71–77
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isoform usage [33]. The annotated FOXP1 isoform
(NM_001012505) is important for differentiation, cell
proliferation and development [34]. However, a novel
exon (18b) was discovered to replace the annotated exon
18 in the traditional isoform NM_001012505, which pro-
duces a novel isoform of FOXP1 in hESCs. The alterna-
tive exon usage changes the protein coding sequence of
the fork-head domain of FOXP1 and consequently
changes the DNA-binding specificities resulting in the
regulation of a different set of target genes. This novel
isoform is specifically expressed by hESCs and contribute
to the regulation of pluripotency genes, such as OCT4,
NR5A2 and NANOG.
Novel splice sites, exons and isoforms are also identified
in the key pluripotency gene NANOG [35]. Novel 5’ end
exons and splices result in various 5’ UTRs and N
terminal domains in Nanog. As a result, two protein
variants attenuate the self-renewal potential and pluripo-
tency in ESCs. Similarly, novel splices in SALL4 and
TCF3 can also change their functions in pluripotency
regulation [31,32].
A large body of evidence have identified alternative
splicing differences between ESCs and differentiated
cell populations [30,31,32]. These studies, exemplify
the importance of large-scale identification of novel iso-
forms of annotated genes and their abundance, especially
for pluripotency-associated genes. Au et al. reported a few
novel isoforms of known pluripotency markers (Table 1
and Figure 2). For example, in the DPPA4 locus, a
RefSeq-annotated isoform is expressed but a novel iso-
form skipping three exons also contributes to a significant
portion (17%) of the total gene abundance. In TERT, a
novel isoform displaying cassette exon skipping junctions
contributes as much as 54% of the gene abundance.Table 1
Isoform identification of pluripotency markers [4].
Pluripotency marker RefSeq isoform identified 
NODAL NM_018055
TDGF1 NM_001174136, NM_003212
PRMT5 NM_001039619, NM_006109
KLF4 NM_004235
TEAD4 NM_003213, NM_201441
E-CADHERIN NM_004360
LIN28A NM_024674
ALPL/TNAP NM_001127501, NM_000478
POU5F1 NM_203289, NM_002701
NANOG NM_024865
DNMT3B 
ZFP42 NM_174900 
SALL4 NM_020436 
DPPA4 NM_018189 
TERT 
Current Opinion in Genetics & Development 2014, 28:71–77 Alternative splicing may be one mechanism of regulation
of the telomerase activity of TERT. As a third example, a
novel exon (not annotated in RefSeq) is observed in an
annotated intron of SALL4, which may lead to a novel
protein variant as observed for FOXP1 [33].
Furthermore it is necessary to identify all novel gene
isoforms from PSCs. Based on the SGS short reads
(75 bp), ENCODE project predicted novel transcripts
from 15 cell lines, including hESCs (H1 cell line) [3].
Although 73,325 transcripts from 31,204 genes in inter-
genic and antisense regions were reported, the detailed
description of novel transcripts from hESCs is lacking.
More importantly, the validation rate by overlapping
targets 454 Life Sciences (Roche) of these novel tran-
scripts (from 15 cell lines) were only 70–90%. In 2013, two
research groups sequenced (by SGS) single-cell human
embryo transcriptomes from oocytes to late blastocyst
[7,8]. With the SGS prediction tools (Cufflinks, Trinity
and PASA), Yan et al. predicted 7420 novel transcripts
from 3866 potential transcription units, including
253 possible protein-coding genes and 7167 possible
novel long non-coding RNAs (lncRNAs) [1,2,36]. How-
ever, the accuracy of transcript prediction by SGS was not
reported. Moreover, Yan et al. imposed a strong arbitrary
constraint on novel transcript unit definition: >10 kb
apart from two transcripts, which narrowed the novel
transcript identification. Au et al. filled the gap of reliable
novel transcript identification by using long reads of TGS.
In Au and colleagues’ experiments, multiple long reads
covered the full lengths of novel or annotated gene iso-
forms or their significant fragments, which resulted in a
very reliable direct detection or prediction under certain
FPR control (<5%). 2103 novel transcripts were ident-
ified which were not annotated by RefSeq, Ensembl,
UCSC Genes or Gencode. Au et al. also predicted
111 lncRNAs from these novel transcripts by very highNovel isoforms identified
Novel isoforms are identified with intron retention events.
A novel isoform has alternative splicing site at the last exon
A novel isoform (with 20% gene abundance) contains novel exon
A novel isoform skips 3 exons
A novel isoform skips exon7 exon8 and exon-skipping junction is
of high expression.
www.sciencedirect.com
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Novel isoform identifications in DPPA4 and SALL4. The browser setting is the same as in Figure 1. The novel junction usages are highlighted in a
pink dashed box. (a) The novel isoform of DPPA4 skips the exon 3, 4, 5 exon (from left to right) of the annotated isoform NM_018189. (b) Exon 4
(from left to right) of novel isoform SALL4.2 is not annotated in RefSeq but in Ensembl. The corresponding isoform ENST00000483130 is fragment
of the IDP-identified isoform in hESCs [4].stringency modes for two ncRNA prediction methods
(P  0.9 for RNAz; MFE  15 and Z score  4 for
alifoldz), 50 of which have specific expression in hESCs.
These novel lncRNAs are much longer and contain more
junctions than the annotated lncRNAs predicted from
SGS, such as Gencode library. Among the novel lncRNAs
identified in Au et al., only 4 of the Gencode-annotated
lncRNAs are longer than 2000 bp, while 72 other novel
lncRNAs (65%) are longer than 2000 bp with the averaged
lengths around 2300 bp; only 6 of Gencode-annotated
lncRNAs contains more than 5 exons, while 78 novel
lncRNAs (70%) contain more than 5 exons. All together,
the study conducted by Au and colleagues, in combination
with other studies of RNA-Seq and sequencing of the
human genome, resulted in the identification of novelwww.sciencedirect.com genes and provided a complete exon structure complexity.
This is particularly important for investigating the func-
tional role of the unique human transcriptome, including
lincRNAs/lncRNAs, and regulative secondary structures in
maintaining pluripotency.
Overall, a comprehensive profiling of hPSC transcriptome
is critical for addressing their pluripotency. However, the
transcriptome research of PSCs is still incomplete. A few
works that focused on new isoforms of annotated genes,
such as NANOG and FOXP1, have shown the import-
ance of characterization of novel transcripts of PSCs.
Thus, some researches, such as ENCODE project and
Au’s work attempted to characterize the whole transcrip-
tome of hESCs. Under a certain control of FRR, Au andCurrent Opinion in Genetics & Development 2014, 28:71–77
76 Cell reprogramming, regeneration and repairhis colleagues provided a list of novel genes and novel
gene isoforms, from which a number of lncRNAs was
predicted and their functions in pluripotency regulation
were studied as well. The previous works could not find
these novel lncRNAs because of their highly repetitive
sequences. Using the latest sequencing techniques, Au’s
method overcame this difficulty. Therefore, more efforts
are needed to expand and optimize this method to more
PSCs, such as iPSC, the other hESC cell lines and embryo
cells. As we complete transcriptome profiling of different
PSCs and the transition stages between them, we will
gain better understanding of pluripotency.
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